A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma

High-grade gliomas (HGGs) carry a dismal prognosis despite current treatments. We previously confirmed the safety and immunogenicity of a vaccine treatment targeting tumor angiogenesis with synthetic peptides, for vascular endothelial growth factor receptor (VEGFR) epitopes in recurrent HGG patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Ryogo, Ueda, Ryo, Saito, Katsuya, Shibao, Shunsuke, Nagashima, Hideaki, Tamura, Ryota, Morimoto, Yukina, Sasaki, Hikaru, Noji, Shinobu, Kawakami, Yutaka, Yoshida, Kazunari, Toda, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406695/
https://www.ncbi.nlm.nih.gov/pubmed/30791546
http://dx.doi.org/10.3390/jcm8020263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406695/
https://www.ncbi.nlm.nih.gov/pubmed/30791546
http://dx.doi.org/10.3390/jcm8020263

Ejemplares similares